Details of the Drug Formulation (DFM)
General Information of DFM (ID: F23345) | |||||
---|---|---|---|---|---|
Name |
Haloperidol Decanoate eq 50mg base/ml injectable
|
||||
Company |
Janssen Pharms
|
||||
Active Pharmaceutical Ingredient (API) | Haloperidol | API Info click to show the detail info of this API | |||
Schizophrenia | ICD-11: 6A20 | Approved | |||
Drug Inactive Ingredient (DIGs) | |||||
DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
E0D6JV | DIG Info | Lactic acid | Acidulant | ||
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
---|---|---|---|---|---|---|
Cell line (CELL) | ||||||
DBT Name: Fetal lung MRC5 cells (MRC5) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Lactic acid | |||||
Biological Activity | IC50 = 23930 nM (estimated based on the structural similarity with CHEMBL330546 ) | [1] | ||||
Structural Similarity | Tanimoto coefficient = 1 | |||||
Tested Species | Homo sapiens (Human) | |||||
Cellosaurus ID | CVCL_0440 | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.